Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Does the patient know best? Quality of life assessment in multiple sclerosis trials.
Origin and differentiation of microglia.
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study.
Hope for a rare disease: eculizumab in neuromyelitis optica.
The Puerto Rico study for the prevalence of Multiple Sclerosis.
Signaling and Regulatory Functions of Bioactive Sphingolipids as Therapeutic Targets in Multiple Sclerosis.
Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis.
Environment may play significant role in multiple sclerosis.
Regional but Not Global Brain Damage Contributes to Fatigue in Multiple Sclerosis.
The history of neuromyelitis optica.
Xavier Montalban: a pioneer in understanding multiple sclerosis.
The nervous system's potential role in multiple sclerosis associated bone loss.
Stress, Depression and Antidepressant Treatment Options in Patients Suffering from Multiple Sclerosis.
Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients.
The effect of intravenous immunoglobulin on neuromyelitis optica.
The intention to exercise and the execution of exercise among persons with multiple sclerosis - a qualitative metasynthesis.
Acquired channelopathies as contributors to development and progression of multiple sclerosis.
Multiple sclerosis, solitary sclerosis or something else?
Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes.
The life extension protein Klotho enhances remyelination following cuprizone-induced demyelination
Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles.
Clonal Expansion of Mitochondrial DNA Deletions and the Progression of Multiple Sclerosis.
Expression of Ccl11 Associates with Immune Response Modulation and Protection against Neuroinflammation in Rats.
Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica.
Alcohol as a Modifiable Lifestyle Factor Affecting Multiple Sclerosis Risk.

Pages